BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8550324)

  • 21. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aprotinin treatment of pseudomonal corneal infection.
    Stuart JC; Turgeon PT; Kowalski RP
    Cornea; 1991 Jan; 10(1):63-6. PubMed ID: 1708325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
    Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis.
    Nos-Barbera S; Portoles M; Morilla A; Ubach J; Andreu D; Paterson CA
    Cornea; 1997 Jan; 16(1):101-6. PubMed ID: 8985641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a synthetic metalloproteinase inhibitor on corneal ulceration in alkali burns and pseudomonas keratitis.
    Burns FR; Gray RD; Wells JT; Paterson CA
    Matrix Suppl; 1992; 1():317-8. PubMed ID: 1480049
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury.
    Sotozono C; He J; Tei M; Honma Y; Kinoshita S
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2430-4. PubMed ID: 10476814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus infection of the rabbit cornea following topical administration.
    Tang A; Balzli CL; Caballero AR; McCormick CC; Taylor SD; O'Callaghan RJ
    Curr Eye Res; 2012 Dec; 37(12):1075-83. PubMed ID: 22916736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internalization of Pseudomonas aeruginosa is mediated by lipid rafts in contact lens-wearing rabbit and cultured human corneal epithelial cells.
    Yamamoto N; Yamamoto N; Petroll MW; Cavanagh HD; Jester JV
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1348-55. PubMed ID: 15790901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model.
    Uwaydat S; Jha P; Tytarenko R; Brown H; Wiggins M; Bora PS; Bora NS
    Curr Eye Res; 2011 Sep; 36(9):787-96. PubMed ID: 21812661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaylsis of birefringence during wound healing and remodeling following alkali burns in rabbit cornea.
    Huang Y; Meek KM; Ho MW; Paterson CA
    Exp Eye Res; 2001 Oct; 73(4):521-32. PubMed ID: 11825023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor.
    Tang A; Caballero AR; Marquart ME; Bierdeman MA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5993-6002. PubMed ID: 30572344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa LasA protease and corneal infections.
    Alionte LG; Cannon BM; White CD; Caballero AR; O'Callaghan RJ; Hobden JA
    Curr Eye Res; 2001 Apr; 22(4):266-71. PubMed ID: 11462165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of matrix metalloproteinase inhibitor on pseudomonal proteinases].
    Kosaku K; Maeda N; Yokoyama T; Inoue T; Yoshida Y; Hosokawa T; Sawa M
    Nippon Ganka Gakkai Zasshi; 1998 Feb; 102(2):83-7. PubMed ID: 9513352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of ovomacroglobulin on bacterial keratitis in rabbits.
    Miyagawa S; Kamata R; Matsumoto K; Okamura R; Maeda H
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):281-6. PubMed ID: 1869068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1975 Dec; 45(6):515-24. PubMed ID: 822189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.